Age and frailty in COVID-19 vaccine development
Melissa K. Andrew, Janet E. McElhaney
Topics & Concepts
MedicineImmunogenicityPopulationRandomized controlled trialScopusOlder peoplePandemicRegimenCoronavirus disease 2019 (COVID-19)GerontologyMEDLINEInternal medicineImmunologyDiseaseAntibodyLawPolitical scienceEnvironmental healthInfectious disease (medical specialty)Frailty in Older AdultsIntensive Care Unit Cognitive DisordersLong-Term Effects of COVID-19